Teneligliptin: Frequently Asked Questions Answered
What is Teneligliptin?
Teneligliptin is one of the newer anti-diabetic medications. It is an oral medicine used in the treatment of type 2 diabetes mellitus (T2DM) in adults.
Teneligliptin was created in 2012 by Mitsubishi Tanabe Pharma in Japan. It has a unique J-shaped molecular structure with five consecutive rings. It belongs to a category of anti-diabetic drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. It is more potent and delivers a long-lasting effect in treating T2DM or adult-onset diabetes.
What are the uses of Teneligliptin?
Teneligliptin improves glycaemic control while avoiding the risk of glucose deficiency (hypoglycemia) and weight gain. Therefore, its primary use is in treating adult-onset diabetes.
Teneligliptin works on the enzymes and hormones that increase glucose levels. As a DPP-4 inhibitor, it limits the dipeptidyl peptidase-4 enzyme’s action. It reduces glucagon – a peptide hormone the pancreas releases – that increases blood glucose levels. Instead, teneligliptin stimulates insulin production in the pancreas. This combined action decreases glucose levels, resulting in reduced fasting and post-meal blood sugar levels.